Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

HISAMITSU PHARMACEUTICAL CO INC Raises Consolidated Mid-year Forecast for FY 2014


Monday, 30 Sep 2013 10:00pm EDT 

HISAMITSU PHARMACEUTICAL CO INC announced that it has raised the consolidated mid-year forecast for revenue from JPY 76,800 million to JPY 77,300 million, operating profit from JPY 10,000 million to JPY 12,400 million, ordinary profit from JPY 13,600 million to JPY 16,800 million, net profit from JPY 11,500 million to JPY 13,600 million and earning per share from JPY 134.24 to JPY 158.75 for the fiscal year ending February 28, 2014. The Company raised the consolidated mid-year outlook due to decreased expenses. 

Company Quote

4505.0
 --
4 Mar 2015